Methdilazine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H20N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0GSO02UEZ, chemically known as 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, monohydrochloride but more generally known as methdilazine hydrochloride, which bears US NIH Compound Identifier 14676. European Medicines Agency schedules Methdilazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03213MIG. Most nations, for tariff and trade purposes, schedule methdilazine hydrochloride under HS 29343090 and SITC 51578. As of Q4 2014, METHDILAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Methdilazine hydrochloride bears US NLM identifiers UMLS ID C0304371 and NCI Concept Code C63950. SMILES: CN1CCC(C1)CN2C3CCCCC3SC4C2CCCC4.CL.